Production (Stage)
Knight Therapeutics Inc.
KHTRF
$4.17
-$0.289-6.48%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.83M | 2.94M | -22.61M | -15.52M | -12.73M |
| Total Depreciation and Amortization | 36.83M | 38.09M | 36.55M | 36.94M | 36.37M |
| Total Amortization of Deferred Charges | 662.90K | 662.90K | 648.30K | 648.30K | 648.30K |
| Total Other Non-Cash Items | -5.30M | -855.90K | 25.78M | 23.26M | 20.31M |
| Change in Net Operating Assets | -33.53M | -14.00M | -1.39M | 1.28M | 1.70M |
| Cash from Operations | 6.49M | 26.84M | 38.98M | 46.61M | 46.29M |
| Capital Expenditure | -1.44M | -1.85M | -1.77M | -1.67M | -1.28M |
| Sale of Property, Plant, and Equipment | 94.50K | 116.60K | 1.46M | 1.46M | 1.46M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.66M | 13.60M | -2.11M | 15.99M | 10.14M |
| Cash from Investing | 52.32M | 11.86M | -2.43M | 15.78M | 10.31M |
| Total Debt Issued | 4.74M | 3.47M | 2.93M | 4.00M | 4.69M |
| Total Debt Repaid | -21.62M | -21.52M | -25.65M | -25.97M | -23.94M |
| Issuance of Common Stock | 1.04M | 1.00M | 957.00K | 597.00K | 362.00K |
| Repurchase of Common Stock | -12.21M | -8.87M | -22.80M | -30.16M | -42.87M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.29M | -7.63M | -9.32M | -9.67M | -10.18M |
| Cash from Financing | -25.43M | -24.30M | -39.57M | -45.07M | -53.21M |
| Foreign Exchange rate Adjustments | 1.49M | 1.17M | 341.70K | 17.00K | 1.74M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.88M | 15.57M | -2.68M | 17.33M | 5.14M |